Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
11 2019
Historique:
received: 22 10 2018
revised: 02 07 2019
accepted: 14 07 2019
pubmed: 29 9 2019
medline: 1 9 2020
entrez: 28 9 2019
Statut: ppublish

Résumé

The Multidomain Alzheimer Preventive Trial (MAPT) assessed the efficacy of omega-3 fatty acid supplementation, a multidomain intervention (MI), or a combination of both on cognition. Impact according to cerebral amyloid status was evaluated by PET scan. Participants were nondemented and had memory complaints, limitation in one instrumental activity of daily living, or slow gait. The primary outcome was a change from baseline in 36 months measured with a cognitive composite Z score. No effect was observed on cognition in the negative amyloid group (n = 167). In the positive amyloid group (n = 102), we observed a difference of 0.708 and 0.471 in the cognitive composite score between the MI plus omega-3 fatty acid group, the MI alone group, and the placebo group, respectively. MI alone or in combination with omega-3 fatty acids was associated with improved primary cognitive outcome in subjects with positive amyloid status. ClinicalTrials.gov Identifier: NCT01513252.

Identifiants

pubmed: 31558366
pii: S1552-5260(19)35131-3
doi: 10.1016/j.jalz.2019.07.008
pii:
doi:

Substances chimiques

Amyloid 0
Fatty Acids, Omega-3 0

Banques de données

ClinicalTrials.gov
['NCT01513252']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1392-1401

Subventions

Organisme : NIA NIH HHS
ID : U19 AG024904
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH098062
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH101472
Pays : United States

Informations de copyright

Copyright © 2019 the Alzheimer's Association. All rights reserved.

Auteurs

Julien Delrieu (J)

INSERM UMR 1027, Toulouse, France; University of Toulouse III, Toulouse, France; Gérontopôle, Department of Geriatrics, Toulouse (University Hospital) CHU, Purpan University Hospital, Toulouse, France. Electronic address: delrieu.j@chu-toulouse.fr.

Pierre Payoux (P)

Department of Nuclear Medicine, Toulouse CHU, Purpan University Hospital, Toulouse, France; Toulouse NeuroImaging Center, University of Toulouse, INSERM, UPS, Toulouse, France.

Isabelle Carrié (I)

Gérontopôle, Department of Geriatrics, Toulouse CHU, Purpan University Hospital, Toulouse, France.

Christelle Cantet (C)

INSERM UMR 1027, Toulouse, France; University of Toulouse III, Toulouse, France; Gérontopôle, Department of Geriatrics, Toulouse (University Hospital) CHU, Purpan University Hospital, Toulouse, France.

Michael Weiner (M)

Department of radiology and biomedical imaging University of California, San Francisco, San Francisco, CA, USA.

Bruno Vellas (B)

INSERM UMR 1027, Toulouse, France; University of Toulouse III, Toulouse, France; Gérontopôle, Department of Geriatrics, Toulouse (University Hospital) CHU, Purpan University Hospital, Toulouse, France.

Sandrine Andrieu (S)

INSERM UMR 1027, Toulouse, France; University of Toulouse III, Toulouse, France; Department of Epidemiology and Public Health, Toulouse CHU, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH